Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCB1 | P08183 | 1/20 | 0.61 |
| ▸ | KCNA3 | P22001 | 2/20 | 0.56 |
| ▸ | SLC5A1 | P13866 | 2/20 | 0.46 |
| ▸ | SLC5A2 | P31639 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 5/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | MAOB | P27338 | 3/20 | 0.45 |
| ▸ | MAOA | P21397 | 2/20 | 0.45 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | BACE1 | P56817 | 1/20 | 0.42 |
| ▸ | CXCL12 | P48061 | 1/20 | 0.41 |
| ▸ | ABCG2 | Q9UNQ0 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25952454 | 1.00 | ABCB1 (0.61) | ABCB1KCNA3SLC5A1SLC5A2MAPT | |
| SCHEMBL25952507 | 0.93 | ABCB1 (0.61) | ABCB1KCNA3SLC5A1SLC5A2MAPT | |
| SCHEMBL25952460 | 0.92 | ABCB1 (0.60) | ABCB1KCNA3SLC5A1SLC5A2MAPT | |
| SCHEMBL25342585 | 0.92 | ABCB1 (0.60) | ABCB1KCNA3SLC5A1SLC5A2MAPT | |
| SCHEMBL25952463 | 0.92 | ABCB1 (0.60) | ABCB1KCNA3SLC5A1SLC5A2MAPT | |
| SCHEMBL25339626 | 0.92 | ABCB1 (0.60) | ABCB1KCNA3SLC5A1SLC5A2MAPT | |
| SCHEMBL25341084 | 0.91 | ABCB1 (0.59) | ABCB1KCNA3SLC5A1SLC5A2MAPT | |
| SCHEMBL25429661 | 0.91 | ABCB1 (0.59) | ABCB1KCNA3MAPTALDH1A1LMNA | |
| SCHEMBL25952401 | 0.91 | ABCB1 (0.59) | ABCB1KCNA3MAPTALDH1A1LMNA | |
| SCHEMBL25952448 | 0.91 | ABCB1 (0.59) | ABCB1KCNA3SLC5A1SLC5A2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023177191-A1 | COMPOSITION FOR PREVENTING OR TREATING FIBROTIC DISEASES, COMPRISING DIMETHYLCHALCONE DERIVATIVE AS ACTIVE INGREDIENT | 서울대학교 산학협력단 | 2023-09-21 | — | — | WO | disclosed |
| US-20230248665-A1 | COMPOSITION COMPRISING DIMETHYLCHALCONE DERIVATIVE FOR PREVENTION OR TREATMENT OF METABOLIC DISEASE | SEOUL NATIONAL UNIVERSITY R & DB FOUNDATION (KR) | 2023-08-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230248665-A1 | COMPOSITION COMPRISING DIMETHYLCHALCONE DERIVATIVE FOR PREVENTION OR TREATMENT OF METABOLIC DISEASE | LIPC, PC, CYP27A1 | ABCB1 3180/4885KCNA3 4014/4885SLC5A1 170/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.